Claudia Benavente is awarded a $2.1 million NCI grant to combat childhood bone cancer
Claudia Benavente, an assistant professor of pharmaceutical sciences and developmental & cell biology at UCI, has received a $2.1 million grant from the National Cancer Institute to develop a novel therapeutic treatment for osteosarcoma. Her research aims to explain the role of the chromatin remodeling protein UHRF1 as a potential target in the treatment of […]
June 06, 2019
